Global Carcinoembryonic Antigen (CEA) Market Size, Status and Forecast 2025

June 2018 | 90 pages | ID: GEC884579C4EN
QYResearch

Abstracts

This report studies the global Carcinoembryonic Antigen (CEA) market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Carcinoembryonic Antigen (CEA) market by companies, region, type and end-use industry.
In 2017, the global Carcinoembryonic Antigen (CEA) market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.

This report focuses on the global top players, covered

• Roche Diagnostics
• Correlogic Systems
• Abbott Diagnostics
• GenWay Biotech
• Quest Diagnostics

Market segment by Regions/Countries, this report covers

• United States
• Europe
• China
• Japan
• Southeast Asia
• India

Market segment by Type, the product can be split into

• Type I
• Type II

Market segment by Application, split into

• Colorectal
• Pancreatic
• Ovarian
• Breast
• Thyroid Cancer

The study objectives of this report are:

• To study and forecast the market size of Carcinoembryonic Antigen (CEA) in global market.
• To analyze the global key players, SWOT analysis, value and global market share for top players.
• To define, describe and forecast the market by type, end use and region.
• To analyze and compare the market status and forecast between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
• To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To identify significant trends and factors driving or inhibiting the market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
• To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Carcinoembryonic Antigen (CEA) are as follows:

• History Year: 2013-2017
• Base Year: 2017
• Estimated Year: 2018
• Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Carcinoembryonic Antigen (CEA) Manufacturers
Carcinoembryonic Antigen (CEA) Distributors/Traders/Wholesalers
Carcinoembryonic Antigen (CEA) Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Carcinoembryonic Antigen (CEA) market, by end-use.
Detailed analysis and profiles of additional market players.

Contents

Global Carcinoembryonic Antigen (CEA) Market Size, Status and Forecast 2025

1 INDUSTRY OVERVIEW OF CARCINOEMBRYONIC ANTIGEN (CEA)

1.1 Carcinoembryonic Antigen (CEA) Market Overview
  1.1.1 Carcinoembryonic Antigen (CEA) Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Carcinoembryonic Antigen (CEA) Market Size and Analysis by Regions (2013-2018)
  1.2.1 United States
  1.2.2 Europe
  1.2.3 China
  1.2.4 Japan
  1.2.5 Southeast Asia
  1.2.6 India
1.3 Carcinoembryonic Antigen (CEA) Market by Type
  1.3.1 Type I
  1.3.2 Type II
1.4 Carcinoembryonic Antigen (CEA) Market by End Users/Application
  1.4.1 Colorectal
  1.4.2 Pancreatic
  1.4.3 Ovarian
  1.4.4 Breast
  1.4.5 Thyroid Cancer

2 GLOBAL CARCINOEMBRYONIC ANTIGEN (CEA) COMPETITION ANALYSIS BY PLAYERS

2.1 Carcinoembryonic Antigen (CEA) Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 Roche Diagnostics
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Carcinoembryonic Antigen (CEA) Revenue (Million USD) (2013-2018)
3.2 Correlogic Systems
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Carcinoembryonic Antigen (CEA) Revenue (Million USD) (2013-2018)
3.3 Abbott Diagnostics
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Carcinoembryonic Antigen (CEA) Revenue (Million USD) (2013-2018)
3.4 GenWay Biotech
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Carcinoembryonic Antigen (CEA) Revenue (Million USD) (2013-2018)
3.5 Quest Diagnostics
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Carcinoembryonic Antigen (CEA) Revenue (Million USD) (2013-2018)

4 GLOBAL CARCINOEMBRYONIC ANTIGEN (CEA) MARKET SIZE BY TYPE AND APPLICATION (2013-2018)

4.1 Global Carcinoembryonic Antigen (CEA) Market Size by Type (2013-2018)
4.2 Global Carcinoembryonic Antigen (CEA) Market Size by Application (2013-2018)
4.3 Potential Application of Carcinoembryonic Antigen (CEA) in Future
4.4 Top Consumer/End Users of Carcinoembryonic Antigen (CEA)

5 UNITED STATES CARCINOEMBRYONIC ANTIGEN (CEA) DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Carcinoembryonic Antigen (CEA) Market Size (2013-2018)
5.2 United States Carcinoembryonic Antigen (CEA) Market Size and Market Share by Players (2013-2018)
5.3 United States Carcinoembryonic Antigen (CEA) Market Size by Application (2013-2018)

6 EUROPE CARCINOEMBRYONIC ANTIGEN (CEA) DEVELOPMENT STATUS AND OUTLOOK

6.1 Europe Carcinoembryonic Antigen (CEA) Market Size (2013-2018)
6.2 Europe Carcinoembryonic Antigen (CEA) Market Size and Market Share by Players (2013-2018)
6.3 Europe Carcinoembryonic Antigen (CEA) Market Size by Application (2013-2018)

7 CHINA CARCINOEMBRYONIC ANTIGEN (CEA) DEVELOPMENT STATUS AND OUTLOOK

7.1 China Carcinoembryonic Antigen (CEA) Market Size (2013-2018)
7.2 China Carcinoembryonic Antigen (CEA) Market Size and Market Share by Players (2013-2018)
7.3 China Carcinoembryonic Antigen (CEA) Market Size by Application (2013-2018)

8 JAPAN CARCINOEMBRYONIC ANTIGEN (CEA) DEVELOPMENT STATUS AND OUTLOOK

8.1 Japan Carcinoembryonic Antigen (CEA) Market Size (2013-2018)
8.2 Japan Carcinoembryonic Antigen (CEA) Market Size and Market Share by Players (2013-2018)
8.3 Japan Carcinoembryonic Antigen (CEA) Market Size by Application (2013-2018)

9 SOUTHEAST ASIA CARCINOEMBRYONIC ANTIGEN (CEA) DEVELOPMENT STATUS AND OUTLOOK

9.1 Southeast Asia Carcinoembryonic Antigen (CEA) Market Size (2013-2018)
9.2 Southeast Asia Carcinoembryonic Antigen (CEA) Market Size and Market Share by Players (2013-2018)
9.3 Southeast Asia Carcinoembryonic Antigen (CEA) Market Size by Application (2013-2018)

10 INDIA CARCINOEMBRYONIC ANTIGEN (CEA) DEVELOPMENT STATUS AND OUTLOOK

10.1 India Carcinoembryonic Antigen (CEA) Market Size (2013-2018)
10.2 India Carcinoembryonic Antigen (CEA) Market Size and Market Share by Players (2013-2018)
10.3 India Carcinoembryonic Antigen (CEA) Market Size by Application (2013-2018)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2018-2025)

11.1 Global Carcinoembryonic Antigen (CEA) Market Size (Value) by Regions (2018-2025)
  11.1.1 United States Carcinoembryonic Antigen (CEA) Revenue and Growth Rate (2018-2025)
  11.1.2 Europe Carcinoembryonic Antigen (CEA) Revenue and Growth Rate (2018-2025)
  11.1.3 China Carcinoembryonic Antigen (CEA) Revenue and Growth Rate (2018-2025)
  11.1.4 Japan Carcinoembryonic Antigen (CEA) Revenue and Growth Rate (2018-2025)
  11.1.5 Southeast Asia Carcinoembryonic Antigen (CEA) Revenue and Growth Rate (2018-2025)
  11.1.6 India Carcinoembryonic Antigen (CEA) Revenue and Growth Rate (2018-2025)
11.2 Global Carcinoembryonic Antigen (CEA) Market Size (Value) by Type (2018-2025)
11.3 Global Carcinoembryonic Antigen (CEA) Market Size by Application (2018-2025)

12 CARCINOEMBRYONIC ANTIGEN (CEA) MARKET DYNAMICS

12.1 Carcinoembryonic Antigen (CEA) Market Opportunities
12.2 Carcinoembryonic Antigen (CEA) Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Carcinoembryonic Antigen (CEA) Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Carcinoembryonic Antigen (CEA) Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Global Carcinoembryonic Antigen (CEA) Market Size (Million USD) Status and Outlook (2013-2018)
Table Global Carcinoembryonic Antigen (CEA) Revenue (Million USD) Comparison by Regions (2013-2018)
Figure Global Carcinoembryonic Antigen (CEA) Market Share by Regions (2013-2018)
Figure United States Carcinoembryonic Antigen (CEA) Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Europe Carcinoembryonic Antigen (CEA) Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure China Carcinoembryonic Antigen (CEA) Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Japan Carcinoembryonic Antigen (CEA) Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Southeast Asia Carcinoembryonic Antigen (CEA) Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure India Carcinoembryonic Antigen (CEA) Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Table Global Carcinoembryonic Antigen (CEA) Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)
Figure Global Carcinoembryonic Antigen (CEA) Revenue Market Share by Type in 2017
Figure Type I Market Size (Million USD) and Growth Rate (2013-2018)
Figure Type II Market Size (Million USD) and Growth Rate (2013-2018)
Figure Global Carcinoembryonic Antigen (CEA) Market Share by Application in 2017
Figure Carcinoembryonic Antigen (CEA) Market Size (Million USD) and Growth Rate in Colorectal (2013-2018)
Figure Carcinoembryonic Antigen (CEA) Market Size (Million USD) and Growth Rate in Pancreatic (2013-2018)
Figure Carcinoembryonic Antigen (CEA) Market Size (Million USD) and Growth Rate in Ovarian (2013-2018)
Figure Carcinoembryonic Antigen (CEA) Market Size (Million USD) and Growth Rate in Breast (2013-2018)
Figure Carcinoembryonic Antigen (CEA) Market Size (Million USD) and Growth Rate in Thyroid Cancer (2013-2018)
Table Carcinoembryonic Antigen (CEA) Market Size (Million USD) by Players (2013-2018)
Figure Carcinoembryonic Antigen (CEA) Market Size Share by Players in 2013
Figure Carcinoembryonic Antigen (CEA) Market Size Share by Players in 2017
Table Roche Diagnostics Basic Information List
Table Carcinoembryonic Antigen (CEA) Business Revenue (Million USD) of Roche Diagnostics (2013-2018)
Figure Roche Diagnostics Carcinoembryonic Antigen (CEA) Business Revenue Market Share (2013-2018)
Table Correlogic Systems Basic Information List
Table Carcinoembryonic Antigen (CEA) Business Revenue (Million USD) of Correlogic Systems (2013-2018)
Figure Correlogic Systems Carcinoembryonic Antigen (CEA) Business Revenue Market Share (2013-2018)
Table Abbott Diagnostics Basic Information List
Table Carcinoembryonic Antigen (CEA) Business Revenue (Million USD) of Abbott Diagnostics (2013-2018)
Figure Abbott Diagnostics Carcinoembryonic Antigen (CEA) Business Revenue Market Share (2013-2018)
Table GenWay Biotech Basic Information List
Table Carcinoembryonic Antigen (CEA) Business Revenue (Million USD) of GenWay Biotech (2013-2018)
Figure GenWay Biotech Carcinoembryonic Antigen (CEA) Business Revenue Market Share (2013-2018)
Table Quest Diagnostics Basic Information List
Table Carcinoembryonic Antigen (CEA) Business Revenue (Million USD) of Quest Diagnostics (2013-2018)
Figure Quest Diagnostics Carcinoembryonic Antigen (CEA) Business Revenue Market Share (2013-2018)
Table Global Carcinoembryonic Antigen (CEA) Market Size (Million USD) by Product (2013-2018)
Figure Global Carcinoembryonic Antigen (CEA) Revenue Market Share (%) by Product (2013-2018)
Figure Global Carcinoembryonic Antigen (CEA) Market Share by Product in 2017
Table Global Carcinoembryonic Antigen (CEA) Market Size by Application (2013-2018)
Figure Global Carcinoembryonic Antigen (CEA) Revenue Market Share (%) by Application in 2017
Table Top Consumer/End Users of Carcinoembryonic Antigen (CEA)
Figure United States Carcinoembryonic Antigen (CEA) Market Size (Million USD) and Growth Rate (2013-2018)
Table United States Carcinoembryonic Antigen (CEA) Market Size (Million USD) by Players (2013-2018)
Figure United States Carcinoembryonic Antigen (CEA) Market Size Share by Players in 2013
Figure United States Carcinoembryonic Antigen (CEA) Market Size Share by Players in 2017
Table United States Carcinoembryonic Antigen (CEA) Market Size by Application (2013-2018)
Figure United States Carcinoembryonic Antigen (CEA) Revenue Market Share (%) by Application (2013-2018)
Figure United States Carcinoembryonic Antigen (CEA) Market Size Share by Application in 2017
Figure Europe Carcinoembryonic Antigen (CEA) Market Size (Million USD) and Growth Rate (2013-2018)
Table Europe Carcinoembryonic Antigen (CEA) Market Size (Million USD) by Players (2013-2018)
Figure Europe Carcinoembryonic Antigen (CEA) Market Size Share by Players in 2013
Figure Europe Carcinoembryonic Antigen (CEA) Market Size Share by Players in 2017
Table Europe Carcinoembryonic Antigen (CEA) Market Size by Application (2013-2018)
Figure Europe Carcinoembryonic Antigen (CEA) Revenue Market Share (%) by Application (2013-2018)
Figure Europe Carcinoembryonic Antigen (CEA) Market Size Share by Application in 2017
Figure China Carcinoembryonic Antigen (CEA) Market Size (Million USD) and Growth Rate (2013-2018)
Table China Carcinoembryonic Antigen (CEA) Market Size (Million USD) by Players (2013-2018)
Figure China Carcinoembryonic Antigen (CEA) Market Size Share by Players in 2013
Figure China Carcinoembryonic Antigen (CEA) Market Size Share by Players in 2017
Table China Carcinoembryonic Antigen (CEA) Market Size by Application (2013-2018)
Figure China Carcinoembryonic Antigen (CEA) Revenue Market Share (%) by Application (2013-2018)
Figure China Carcinoembryonic Antigen (CEA) Market Size Share by Application in 2017
Figure Japan Carcinoembryonic Antigen (CEA) Market Size (Million USD) and Growth Rate (2013-2018)
Table Japan Carcinoembryonic Antigen (CEA) Market Size (Million USD) by Players (2013-2018)
Figure Japan Carcinoembryonic Antigen (CEA) Market Size Share by Players in 2013
Figure Japan Carcinoembryonic Antigen (CEA) Market Size Share by Players in 2017
Table Japan Carcinoembryonic Antigen (CEA) Market Size by Application (2013-2018)
Figure Japan Carcinoembryonic Antigen (CEA) Revenue Market Share (%) by Application (2013-2018)
Figure Japan Carcinoembryonic Antigen (CEA) Market Size Share by Application in 2017
Figure Southeast Asia Carcinoembryonic Antigen (CEA) Market Size (Million USD) and Growth Rate (2013-2018)
Table Southeast Asia Carcinoembryonic Antigen (CEA) Market Size (Million USD) by Players (2013-2018)
Figure Southeast Asia Carcinoembryonic Antigen (CEA) Market Size Share by Players in 2013
Figure Southeast Asia Carcinoembryonic Antigen (CEA) Market Size Share by Players in 2017
Table Southeast Asia Carcinoembryonic Antigen (CEA) Market Size by Application (2013-2018)
Figure Southeast Asia Carcinoembryonic Antigen (CEA) Revenue Market Share (%) by Application (2013-2018)
Figure Southeast Asia Carcinoembryonic Antigen (CEA) Market Size Share by Application in 2017
Figure India Carcinoembryonic Antigen (CEA) Market Size (Million USD) and Growth Rate (2013-2018)
Table India Carcinoembryonic Antigen (CEA) Market Size (Million USD) by Players (2013-2018)
Figure India Carcinoembryonic Antigen (CEA) Market Size Share by Players in 2013
Figure India Carcinoembryonic Antigen (CEA) Market Size Share by Players in 2017
Table India Carcinoembryonic Antigen (CEA) Market Size by Application (2013-2018)
Figure India Carcinoembryonic Antigen (CEA) Revenue Market Share (%) by Application (2013-2018)
Figure India Carcinoembryonic Antigen (CEA) Market Size Share by Application in 2017
Figure Global Carcinoembryonic Antigen (CEA) Market Size and Growth Rate (2018-2025)
Table Global Carcinoembryonic Antigen (CEA) Market Size (Million USD) by Regions (2018-2025)
Figure Global Carcinoembryonic Antigen (CEA) Market Size Share (2018-2025)
Figure Global Carcinoembryonic Antigen (CEA) Market Size Share by Regions in 2025
Figure United States Carcinoembryonic Antigen (CEA) Revenue (Million USD) and Growth Rate (2018-2025)
Figure Europe Carcinoembryonic Antigen (CEA) Revenue (Million USD) and Growth Rate (2018-2025)
Figure China Carcinoembryonic Antigen (CEA) Revenue (Million USD) and Growth Rate (2018-2025)
Figure Japan Carcinoembryonic Antigen (CEA) Revenue (Million USD) and Growth Rate (2018-2025)
Figure Southeast Asia Carcinoembryonic Antigen (CEA) Revenue (Million USD) and Growth Rate (2018-2025)
Figure India Carcinoembryonic Antigen (CEA) Revenue (Million USD) and Growth Rate (2018-2025)
Table Global Carcinoembryonic Antigen (CEA) Market Size (Million USD) by Type (2018-2025)
Figure Global Carcinoembryonic Antigen (CEA) Market Size Share by Type in 2018
Figure Global Carcinoembryonic Antigen (CEA) Market Size Share by Type in 2025
Table Global Carcinoembryonic Antigen (CEA) Market Size (Million USD) by Application (2018-2025)
Figure Global Carcinoembryonic Antigen (CEA) Market Size (Million USD) by Application in 2018